trending Market Intelligence /marketintelligence/en/news-insights/trending/ANTGtvQ21siMtuIVdDJk1A2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Resverlogix to undertake overnight marketed offering of units

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Resverlogix to undertake overnight marketed offering of units

Resverlogix Corp. announced an overnight marketed offering of its common shares and common share purchase warrants.

The Canadian clinical stage biotechnology company has 105,701,543 common shares issued and outstanding.

The offering is led by Bloom Burton Securities Inc. on a best-efforts agency basis.

It is being made in every Canadian province, except Quebec, by way of a prospectus supplement to Resverlogix's base shelf prospectus dated Oct. 1, 2015.

The number and price of units to be distributed, and the exercise price and term of each whole common share purchase warrant will be determined in context of the market.